Gene · 3207
Papers1,952
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 1,952
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The LncRNA MIR503HG/miR-224-5p/TUSC3 Signaling Cascade Suppresses Gastric Cancer Development via Modulating ATF6 Branch of Unfolded Protein Response. | Front Oncol | 2021 | 34381729 | PubTator, text mining | PubMed |
| FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML. | Front Oncol | 2021 | 34381718 | PubTator, text mining | PubMed |
| Epigenetic signatures differentiate uterine and soft tissue leiomyosarcoma. | Oncotarget | 2021 | 34381562 | PubTator, text mining | PubMed |
| Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation. | Cell Death Dis | 2021 | 34381018 | PubTator, text mining | PubMed |
| Long Noncoding RNA MALAT1 Interacts with miR-124-3p to Modulate Osteosarcoma Progression by Targeting SphK1. | J Oncol | 2021 | 34373692 | PubTator, text mining | PubMed |
| Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma. | Nucleic Acids Res | 2021 | 34370013 | PubTator, text mining | PubMed |
| Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review. | Reprod Biol Endocrinol | 2021 | 34362377 | PubTator, text mining | PubMed |
| LINC01355 Contributes to Malignant Phenotype of Oral Squamous Cell Carcinoma and Cytotoxic T Cell Infiltration via Activating Notch Signaling Pathway. | J Immunol Res | 2021 | 34355042 | PubTator, text mining | PubMed |
| Management of endometrial polyps in infertile women: A mini-review. | Clin Exp Reprod Med | 2021 | 34352167 | PubTator, text mining | PubMed |
| Advances in molecular mechanisms of pelvic organ prolapse (Review). | Exp Ther Med | 2021 | 34345291 | PubTator, text mining | PubMed |
| Protective effect of propofol via the regulation of ovarian granulosa cell proliferation and apoptosis. | Exp Ther Med | 2021 | 34345270 | PubTator, text mining | PubMed |
| Copy number variation characterization and possible candidate genes in miscarriage and stillbirth by next-generation sequencing analysis. | J Gene Med | 2021 | 34342101 | PubTator, text mining | PubMed |
| Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. | Aging (Albany NY) | 2021 | 34341185 | PubTator, text mining | PubMed |
| LncRNA HOXA11-AS promotes cell growth by sponging miR-24-3p to regulate JPT1 in prostate cancer. | Eur Rev Med Pharmacol Sci | 2021 | 34337714 | PubTator, text mining | PubMed |
| lncRNA TSPEAR-AS2, a Novel Prognostic Biomarker, Promotes Oral Squamous Cell Carcinoma Progression by Upregulating PPM1A via Sponging miR-487a-3p. | Dis Markers | 2021 | 34336002 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review. | Front Oncol | 2021 | 34322395 | PubTator, text mining | PubMed |
| miR-526b-3p inhibits lung cancer cisplatin-resistance and metastasis by inhibiting STAT3-promoted PD-L1. | Cell Death Dis | 2021 | 34321456 | PubTator, text mining | PubMed |
| Long non-coding RNAs in brain tumors. | NAR Cancer | 2021 | 34316694 | PubTator, text mining | PubMed |
| Current Treatment of Juvenile Myelomonocytic Leukemia. | J Clin Med | 2021 | 34300250 | PubTator, text mining | PubMed |
| Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells. | Cancers (Basel) | 2021 | 34298743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3207/papers?page=32